August 14, 2025

Antidepressants May Benefit IBD Through Shared Mechanisms

Researchers examine how inflammatory bowel disease and depression share biological mechanisms and how treating one may improve outcomes in the other.

Conexiant

August 14, 2025

Greater Variety of Flavonoids Tied to Lower Chronic Disease

Higher diversity and quantity of dietary flavonoid intake were each linked to reduced risks of mortality and major chronic diseases in a large population-based study.

Conexiant

August 13, 2025

Surgery or Surveillance? AI May Help Decide

Multi-center study compares diagnostic accuracy of multiomic model with standard care in pancreatic cysts

The Pathologist

August 12, 2025

Advanced-Practice Providers Filling Rural ER Gaps

Rural emergency rooms across the U.S. are increasingly staffed by physician assistants and nurse practitioners instead of physicians, raising debates over care quality, staffing shortages, and access to emergency services.

KFF Health News

August 11, 2025

FDA OKs Bioequivalent Iron Sucrose for CKD Anemia

The FDA has approved a bioequivalent iron sucrose injection for treating iron deficiency anemia in patients with chronic kidney disease.

Conexiant

August 11, 2025

Why Turning 26 Jeopardizes Health Coverage

A growing number of young Americans lose affordable health insurance at age 26, facing complex Affordable Care Act marketplaces, rising costs, and limited coverage options.

KFF Health News

August 08, 2025

INSL5 Rise Tied to Diarrhea Severity, Treatment

Circulating Insulin-like peptide 5 concentrations may reflect colonic exposure to bile acids and help stratify treatment response in patients with chronic diarrhea.

Conexiant

August 06, 2025

Bimekizumab Sustains Psoriasis Response for 3 Years

A 3-year analysis of a phase IIIb trial found that bimekizumab, a dual interleukin-17A and interleukin-17F inhibitor, maintained high rates of skin clearance and demonstrated a consistent safety profile in patients with moderate-to-severe plaque psoriasis, including those who switched from secukinumab, an interleukin-17A inhibitor.

Conexiant

August 05, 2025

Modified Mesh Repair Effective in Women’s Hernias

Randomized trial results showed that modified open mesh repair was as safe and effective as standard mesh repair for treating groin hernias in women, with similar recurrence and complication rates after 1 year.

Conexiant